Merck & Co., Inc.
6MK.DE
Get informed when a big investor buys or sells
+ FollowMarket Cap$356.4B
Close$
Share Statistics
| Market cap | $356.40 Billion |
|---|---|
| Enterprise Value | $407.68 Billion |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | 7.57% |
|---|---|
| Return on Assets | 2.88% |
| Return on Invested Capital | 12.54% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 6.12 |
| Enterprise Value to EBIT | 39.43 |
| Enterprise Value to Net Income | 128 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 1.39 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Merck & Co Inc
75,000 employees
CEO: Kenneth Frazier Merck & Co., Inc. is a prominent global healthcare enterprise. It operates through two core segments: Human Pharmaceuticals and Animal Health. Its Pharmaceutical segment delivers human health products, including medications for critical ...